- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 115.04M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $12M |
| Capex | Q1 2025 · Mar 31, 2024 | $4.7M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $476M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $429.1M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $81.2M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $78.3M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $20.5M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $106.7M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $430.3M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $476.6M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.13B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.11B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.95B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.91B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 115M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $21.9M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$43.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $774.4M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $808.3M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.07 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.07 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $54.2M |
| Net Income | Q1 2025 · Mar 31, 2024 | $8.1M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $19.5M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $71.5M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $407.3M |
| Revenue | Q1 2025 · Mar 31, 2024 | $478.8M |